e-learning
resources
Glasgow 2004
Monday 06.09.2004
Clinical and diagnostic problems in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lymphopenia as a mortality predictor in non HIV pulmonary TB patients
S. Zareiy, M. S. Mirsaeidi, D. S. Mansouri, M. Amiri, M. Kazempour, M. R. Masjedi, A. A. Velayati (Tehran, Iran)
Source:
Annual Congress 2004 - Clinical and diagnostic problems in tuberculosis
Session:
Clinical and diagnostic problems in tuberculosis
Session type:
Thematic Poster Session
Number:
2611
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Zareiy, M. S. Mirsaeidi, D. S. Mansouri, M. Amiri, M. Kazempour, M. R. Masjedi, A. A. Velayati (Tehran, Iran). Lymphopenia as a mortality predictor in non HIV pulmonary TB patients. Eur Respir J 2004; 24: Suppl. 48, 2611
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Analysis of mortality incidence in patients with pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 555s
Year: 2002
Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012
A prediction rule to stratify mortality risk of patients with pulmonary tuberculosis
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
Prognosis and predictors for mortality in patients with tuberculosis destroyed lung
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Predictors of death in patients with MDR-TB and HIV
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Characteristics and predictors of mortality in patients with pleural infection
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
The assessment of risk factors and treatment of pulmonary TB relapses
Source: Eur Respir J 2006; 28: Suppl. 50, 129s
Year: 2006
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Smoking as a risk factor mortality in pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 191s
Year: 2004
Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with advanced HIV disease
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Impact of seasons on tuberculosis mortality for HIV+ and HIV- TB patients
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
Source: Eur Respir J, 56 (3) 2002439; 10.1183/13993003.02439-2020
Year: 2020
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
Source: Eur Respir J, 56 (3) 2002961; 10.1183/13993003.02961-2020
Year: 2020
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
Prevalence of pulmonary arterial hypertension in HIV positive outpatients in the HAART era
Source: Eur Respir J 2006; 28: Suppl. 50, 545s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept